THE WORLD’S DOCTORS write more than 1,100 prescriptions for GlaxoSmithKline medicines every minute. The company made pre-tax profits of £6.7 billion ($11 billion) last year. Making people better is big business.
UK pharmaceuticals group GSK’s products treat asthma, depression, diabetes, migraine, nicotine addiction and a host of other ailments. But GSK hasn’t always been so multi-faceted. Long before its merger with SmithKline Beecham, Glaxo Wellcome’s growth was largely driven by the success of a single product, Zantac, which soothes ulcers, indigestion and heartburn.
Thanks for your interest in Euromoney!
To unlock this article, enter your e-mail to log in or enquire about access:
